Edition:
United States

Taisho Pharmaceutical Holdings Co Ltd (4581.T)

4581.T on Tokyo Stock Exchange

9,210JPY
2:00am EDT
Change (% chg)

¥-220 (-2.33%)
Prev Close
¥9,430
Open
¥9,400
Day's High
¥9,400
Day's Low
¥9,210
Volume
197,800
Avg. Vol
105,817
52-wk High
¥14,130
52-wk Low
¥9,210

About

TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. is a holding company mainly engaged in the manufacture and sale of pharmaceuticals. The Self-Medication segment is engaged in the research, development, manufacture and sale of general pharmaceuticals, general foods, medical supplies and others. The Medical segment is engaged in the... (more)

Overall

Beta: 0.46
Market Cap(Mil.): ¥850,016.88
Shares Outstanding(Mil.): 90.14
Dividend: 50.00
Yield (%): 1.17

Financials

  4581.T Industry Sector
P/E (TTM): 15.50 52.11 53.45
EPS (TTM): 608.30 -- --
ROI: 6.75 12.01 11.71
ROE: 7.00 13.29 16.35

Bristol-Myers gets $1.6 billion offer for French consumer health unit

Bristol-Myers Squibb Co received an offer from Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd to buy the company's French over-the-counter drugs business UPSA for $1.6 billion, the companies said on Wednesday.

Dec 19 2018

UPDATE 2-Bristol-Myers gets $1.6 bln offer for French consumer health unit

Dec 19 Bristol-Myers Squibb Co received an offer from Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd to buy the company's French over-the-counter drugs business UPSA for $1.6 billion, the companies said on Wednesday.

Dec 19 2018

Bristol-Myers gets $1.6 bln offer for French consumer health unit

Dec 19 Bristol-Myers Squibb Co received an offer from Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd to buy the company's French over-the-counter drugs business UPSA for $1.6 billion, the companies said on Wednesday.

Dec 19 2018

Deals of the day-Mergers and acquisitions

Dec 17 The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Monday:

Dec 17 2018

Taisho said to near $1.6 billion deal for Bristol-Myers's UPSA: Bloomberg

Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd is said to be close to a $1.6 billion deal for Bristol-Myers Squibb Co's French over-the-counter drugs business UPSA, Bloomberg reported on Sunday, citing sources familiar with the matter.

Dec 17 2018

Taisho said to near $1.6 bln deal for Bristol-Myers's UPSA- Bloomberg

Dec 16 Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd is said to be close to a $1.6 billion deal for Bristol-Myers Squibb Co's French over-the-counter drugs business UPSA, Bloomberg reported on Sunday, citing sources familiar with the matter.

Dec 17 2018

Earnings vs. Estimates